119
Participants
Start Date
January 13, 2016
Primary Completion Date
September 2, 2020
Study Completion Date
September 2, 2020
Zanubrutinib
Obinutuzumab
St George Hospital, Kogarah
The Alfred Hospital, Melbourne
St Vincents Hospital Melbourne, Fitzroy
St Frances Xavier Cabrini Hospital, Malvern
Barwon Health the Geelong Hospital, Geelong
Brisbane Clinic For Lymphoma, Greenslopes
Ashford Cancer Centre Research Northeast, Windsor Gardens
Royal Perth Hospital, Perth
Florida Cancer Specialists East, West Palm Beach
Florida Cancer Specialists Fort Myers, Fort Myers
Tennessee Oncology, Nashville
Asan Medical Center, Seoul
Gangnam Severance Hospital, Yonsei University Health System, Seoul
Samsung Medical Center, Seoul
Lead Sponsor
BeiGene
INDUSTRY